The outlook of companies tied to blockbuster drugs like Viagra presents a challenging investment picture. While the initial rise of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the expiry in key markets has introduced significant volatility. Investors are now facing the consequences of rival medications , d